This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Ye Feng: Innovator in Cancer Treatment
Introduction
Ye Feng is a prominent inventor based in Princeton, NJ (US). She has made significant contributions to the field of cancer treatment through her innovative research and development.
Latest Patents
Ye Feng holds a patent for a groundbreaking method titled "Combination therapy with anti-IL-8 antibodies and anti-PD-1 antibodies for treating cancer." This patent outlines methods for the clinical treatment of tumors, particularly advanced solid tumors, in patients with specific levels of serum IL-8. The combination of an anti-IL-8 antibody with an anti-PD-1 antibody represents a novel approach to enhancing cancer therapy.
Career Highlights
Ye Feng is currently employed at Bristol-Myers Squibb Company, where she continues to advance her research in oncology. Her work is pivotal in developing therapies that improve patient outcomes in cancer treatment.
Collaborations
Throughout her career, Ye Feng has collaborated with notable colleagues, including Michael Carleton and David Feltquate. These partnerships have fostered a collaborative environment that enhances innovation and research in cancer therapies.
Conclusion
Ye Feng's contributions to cancer treatment through her patented methods and collaborative efforts highlight her role as a leading inventor in the field. Her work continues to inspire advancements in medical research and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile